Anesiva CEO John P. McLaughlin: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
McLaughlin discusses Anesiva’s newly approved drug Zingo and the firm’s plan to partner the topical local anesthetic in the U.S. and ex-U.S.